Continuation vehicles are here to stay
GP-led transactions are on track to exceed $100bn in 20251, cementing their role as a structural feature of private markets. One in six buyout exits now occurs via a GP-led2 – a dramatic rise from single-digit percentages just a few years ago and 75% of GPs say they will participate in secondaries within the next 2 years3. CVs are no longer considered a stopgap; they are a strategic solution for GPs seeking to retain high-performing assets and maintain AUM stability.
There’s good momentum behind GP-leds. Whether the M&A or IPO markets open back up or not, we’re still going to see significant growth in the GP-led market.
Why the increase in popularity? For GPs, selling prized assets to competitors makes little sense when upside remains. CVs allow managers to take another lap around with their best companies while providing liquidity to existing LPs. For investors, CVs offer flexibility when traditional exits are not an option. Instead of waiting for uncertain IPO or M&A markets, LPs can choose to roll into a new vehicle and maintain exposure to high-performing assets, sell for immediate liquidity, or even increase their stake. This optionality is critical for institutions facing a dearth in distributions and portfolio rebalancing pressures.
00:00 – 00:05
I think GPs can now see how beneficial it is, this...
00:00 – 00:05
I think GPs can now see how beneficial it is, this technology in the secondary market
00:00:05 – 00:00:12
where they can actually hold on to these assets in which they want to continue to hold for longer, even if the exit markets pick up.
00:00:12 – 00:00:16
You hear consistently from the sponsors that they expect to do 1 to 2 assets per fund.
00:00:16 – 00:00:23
So I still anticipate the CV market to be there and to continue alongside a healthy exit market environment.
Backlog in deal activity for next year is twice what it was in 20244, driven by GP-led transactions that require longer lead times. While traditional exit routes may reopen in 2026, CVs are expected to remain prevalent, driven by GPs’ strategic objectives such as preserving AUM and maximising upside on trophy assets. Over the next five years, the market is projected to expand, supported by new capital from wealth platforms, sovereign wealth funds, and insurance investors.
00:00:00 – 00:00:05
I think 2025 is going to be a record year for...
00:00:00 – 00:00:05
I think 2025 is going to be a record year for GP-leds, we’re going to break the 100 billion mark.
00:00:05 – 00:00:14
From everything we can see in our pipeline, we’re gearing up to another record year, potentially in 2026.
00:00:14 – 00:00:24
LPs want liquidity back, GPs want to hold on to their best assets. There’s good momentum behind GP-leds. This is going only one way.
00:00:24 – 00:00:34
We’re going to see significant growth in this market. Whether the M&A market opens up or the IPO market opens up, I think it doesn’t really matter.
00:00:34 – 00:00:37
We’re still going to see significant growth in the GP-led market.
What’s on the horizon? Expect CV-squared transactions – where a continuation vehicle itself becomes the subject of a new CV – to gain traction. Other innovations include hybrid CVs combining preferred equity and debt, CVs with structured liquidity options and NAV-based financing integrated into GP-led deals. These developments point to a future where GP-leds are an even more sophisticated portfolio management tool.
1. Analysis drawn from Jefferies, Evercore, Campbell Lutyens, UBS and William Blair.
2. Ropes & Gray LLP. (2025, October). Secondaries Quarterly Update: Q3 2025.
3. PJT Partners. (2025, January). FY 2024 secondary market update.
4. Nigel Dawn of Evercore. (2025, November). “Market Outlook Panel”, Coller Capital’s New York LP Meeting.